RESUMEN
Dysregulation in the paraventricular nucleus of the hypothalamus (PVN) is associated with a variety of diseases including those related to obesity. Although most investigations have focused on molecular changes, structural alterations in PVN neurons can reveal underlying functional disruptions. Although electron microscopy (EM) can provide nanometer resolution of brain structures, an inherent limitation of traditional transmission EM is the single field of view nature of data collection. To overcome this, we used large-field-of-view high-resolution backscatter scanning electron microscopy (bSEM) of the PVN. By stitching high-resolution bSEM images, taken from normal chow and high-fat diet mice, we achieved interactive, zoomable maps that allow for low-magnification screening of the entire PVN and high-resolution analyses of ultrastructure at the level of the smallest cellular organelle. Using this approach, quantitative analysis across the PVN revealed marked electron-dense regions within neuronal nucleoplasm following high-fat diet feeding, with an increase in kurtosis, indicative of a shift away from a normal distribution. Furthermore, measures of skewness indicated a shift toward darker clustered electron-dense regions, potentially indicative of heterochromatin clusters. We further demonstrate the utility to map out healthy and altered neurons throughout the PVN and the ability to remotely perform bSEM imaging in situations that require social distancing, such as the COVID-19 pandemic. Collectively, these findings present an approach that allows for the precise placement of PVN cells within an overall structural and functional map of the PVN. Moreover, they suggest that obesity may disrupt PVN neuronal chromatin structure.NEW & NOTEWORTHY Paraventricular nucleus of the hypothalamus (PVN) alterations are linked to obesity-related conditions, but limited knowledge exists about neuroanatomical changes in this region. A large-field-of-view backscatter scanning electron microscopy (bSEM) method was used, which allowed the identification of up to 40 PVN neurons in individual samples. During obesity in mice, bSEM revealed changes in PVN neuronal nucleoplasm, possibly indicating chromatin clustering. This microscopy advancement offers valuable insights into neuroanatomy in both healthy and disease conditions.
Asunto(s)
COVID-19 , Núcleo Hipotalámico Paraventricular , Ratones , Animales , Humanos , Microscopía Electrónica de Rastreo , Pandemias , Hipotálamo , Obesidad , Dieta Alta en Grasa/efectos adversosRESUMEN
A role for oxidative stress in the brain has been suggested in the pathogenesis of diet-induced obesity (DIO), although the underlying neural regions and mechanisms remain incompletely defined. We tested the hypothesis that NADPH oxidase-dependent oxidative stress in the paraventricular nucleus (PVN), a hypothalamic energy homeostasis center, contributes to the development of DIO. Cre/LoxP technology was coupled with selective PVN adenoviral microinjection to ablate p22phox , the obligatory subunit for NADPH oxidase activity, in mice harboring a conditional p22phox allele. Selective deletion of p22phox in the PVN protected mice from high-fat DIO independent of changes in food intake or locomotor activity. This was accompanied by ß3-adrenoceptor-dependent increases in energy expenditure, elevations in brown adipose tissue thermogenesis, and browning of white adipose tissue. These data reveal a potentially novel role for brain oxidative stress in the development of DIO by modulating ß3-adrenoceptor mechanisms and point to the PVN as an underlying neural site.
Asunto(s)
Grupo Citocromo b/genética , Dieta Alta en Grasa , Metabolismo Energético/genética , NADPH Oxidasas/genética , Obesidad/genética , Estrés Oxidativo , Núcleo Hipotalámico Paraventricular/metabolismo , Receptores Adrenérgicos beta 3/metabolismo , Termogénesis/genética , Tejido Adiposo Pardo/metabolismo , Tejido Adiposo Blanco/metabolismo , Animales , Encéfalo/metabolismo , Grupo Citocromo b/metabolismo , Ingestión de Alimentos , Hipotálamo/metabolismo , Locomoción , Ratones , NADPH Oxidasas/metabolismo , Obesidad/metabolismoRESUMEN
This case report presents a military diver who became dysphoric and lost consciousness during a routine surface-supplied dive. The patient regained consciousness spontaneously, but the physical exam was notable for bilateral ophthalmoplegia. Full eye movement was regained during hyperbaric oxygen (HBO2) therapy, and the patient subsequently made a full recovery. Equipment and dive profile analysis led to the conclusion of hypercapnia and arterial gas embolism as the probable causes of the diver's symptoms. This is a unique case of isolated bilateral ophthalmoplegia presenting in a diving injury.
Asunto(s)
Buceo/efectos adversos , Oxigenoterapia Hiperbárica , Oftalmoplejía/terapia , Adulto , Arterias , Embolia Aérea/complicaciones , Análisis de Falla de Equipo , Humanos , Hipercapnia/complicaciones , Masculino , Personal Militar , Oftalmoplejía/etiología , Inconsciencia/etiologíaRESUMEN
Submariners spend prolonged periods submerged without sunlight exposure and may benefit from vitamin D supplementation to maintain vitamin D status. The primary objective of this study was to determine the efficacy of daily vitamin D supplementation on maintenance of 25-hydroxyvitamin D (25(OH)D) during a 3-month submarine patrol. Submariners were randomly divided into three groups: placebo (n = 16), 1,000 IU/day (n = 20), or 2,000 IU/day (n = 17). Anthropometrics, self-reported dietary calcium and vitamin D intake, serum markers of vitamin D and bone metabolism, and peripheral quantitative computed tomography (pQCT) parameters of the tibia were determined before and after the patrol. Prior to departure, 49 % of the subjects were vitamin D insufficient (<50 nmol/L). Following the patrol, 25(OH)D increased in all groups (p < 0.001): 3.3 ± 13.1 (placebo), 4.6 ± 11.3 (1,000 IU/day), and 13 ± 14 nmol/L (2,000 IU/day). The changes in 25(OH)D levels were dependent upon the baseline concentration of 25(OH)D and body mass (p < 0.001). Osteocalcin increased by 38 % (p < 0.01), and pQCT analyses revealed small, yet significant increases in indices of tibial structure and strength (p < 0.05) that were independent of supplementation. These data suggest that vitamin D status was low prior to the patrol, and the subsequent changes in vitamin D status were dependent on the baseline 25(OH)D levels and body mass. Furthermore, short-term skeletal health does not appear to be negatively affected by 3 months of submergence in spite of a suboptimal response to vitamin D supplementation.
Asunto(s)
Densidad Ósea/efectos de los fármacos , Suplementos Dietéticos , Medicina Submarina , Vitamina D/administración & dosificación , Vitaminas/administración & dosificación , Adulto , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Humanos , Inmunoensayo , Masculino , Vitamina D/análogos & derivados , Vitamina D/sangre , Deficiencia de Vitamina D/prevención & controlRESUMEN
Oxygen is the most widely used therapeutic strategy to prevent and treat decompression sickness (DCS). Oxygen prebreathe (OPB) eliminated DCS in 20-kg swine after rapid decompression from saturation at 60 feet of seawater (fsw). However, hyperbaric oxygen (HBO) has risks. As oxygen partial pressure increases, so do its toxic effects. Central nervous system (CNS) oxygen toxicity is the most severe side effect, manifesting as seizure. An adjunctive therapeutic is needed to extend OPB strategies to deeper depths and prevent/delay seizure onset. The Food and Drug Administration-approved anti-epileptic vigabatrin has prevented HBO-induced seizures in rats up to 132 fsw. This study aimed to confirm the rat findings in a higher animal model and determine whether acute high-dose vigabatrin evokes retinotoxicity symptoms seen with chronic use clinically in humans. Vigabatrin dose escalation studies were conducted 20-kg swine exposed to HBO at 132 or 165 fsw. The saline group had seizure latencies of 7 and 11 min at 165 and 132 fsw, respectively. Vigabatrin at 180 mg/kg significantly increased latency (13 and 27 min at 165 and 132 fsw, respectively); 250 mg/kg abolished seizure activity at all depths. Functional electroretinogram and histology of the retinas showed no signs of retinal toxicity in any of the vigabatrin=treated animals. In the 250 mg/kg group there was no evidence of CNS oxygen toxicity; however, pulmonary oxygen toxicity limited HBO exposure. Together, the findings from this study show that vigabatrin therapy is efficacious at preventing CNS oxygen toxicity in swine, and a single dose is not acutely associated with retinotoxicity.
Asunto(s)
Anticonvulsivantes/farmacología , Oxigenoterapia Hiperbárica/efectos adversos , Hiperoxia/tratamiento farmacológico , Convulsiones/prevención & control , Vigabatrin/farmacología , Animales , Anticonvulsivantes/efectos adversos , Descompresión/métodos , Enfermedad de Descompresión/prevención & control , Modelos Animales de Enfermedad , Buceo/efectos adversos , Frecuencia Cardíaca/efectos de los fármacos , Hiperoxia/complicaciones , Masculino , Ratas , Retina/efectos de los fármacos , Retina/fisiología , Convulsiones/etiología , Sus scrofa , Vigabatrin/efectos adversosRESUMEN
A 26-year-old male was presented to a military treatment facility in Afghanistan shortly after taking a weight-lifting supplement called Jack3d with a severe headache and was subsequently found to have suffered a Dejerine-Roussy variant right thalamic hemorrhagic stroke. Jack3d active ingredients include geranamine, schizandrol A, caffeine, beta-alanine, creatine monohydrate, and L-arginine alpha-ketoglutarate. A literature search revealed case reports suggesting some of the constituent ingredients may predispose to stroke and hemorrhage and also revealed a substantial paucity of data existed regarding schizandrol A, a herb used in traditional eastern medicine. The product has no readily apparent disclaimer or warning regarding the risks or lack of data regarding the components. Jack3d is sold as a nutritional supplement and is therefore not subject to same FDA regulation and scrutiny that a pharmaceutical receives. The potential adverse effect was reported to the FDA via MedWatch in accordance with the recently passed Dietary Supplement and Nonprescription Drug Consumer Protection Act.
Asunto(s)
Suplementos Dietéticos/efectos adversos , Hemorragias Intracraneales/inducido químicamente , Accidente Vascular Cerebral Lacunar/inducido químicamente , Adulto , Aminas/efectos adversos , Aminas/análisis , Humanos , Hemorragias Intracraneales/diagnóstico , Masculino , Personal Militar , Accidente Vascular Cerebral Lacunar/diagnóstico , Simpatomiméticos/efectos adversos , Simpatomiméticos/análisis , Enfermedades Talámicas/inducido químicamente , Tomografía Computarizada por Rayos XRESUMEN
OBJECTIVE: This is a pilot study to describe patterns of nutritional supplement use by recruits entering the U.S. Marine Corps (USMC). METHODS: A survey asking USMC recruits to self-report nutritional supplement use was administered upon entry to basic training. Simple descriptive statistics and prevalence ratios were used to describe patterns of supplement use. RESULTS: The response rate was 65%. Half of respondents reported nutritional sports supplement use at some point before boot camp. The five most commonly supplements were: protein powder (43%), postrecovery workout drinks (36%), vitamin supplements (26%), creatine (26%), and nitric oxide (16%). CONCLUSIONS: Nutritional supplement use is frequent among recruits entering the USMC. The impact of supplement use on recruit fitness, training, and injury rates is not known.